搜尋結果
2025
Hsieh, Y. C. ,
Cheng, T. H. ,
Wang, C. A. ,
Hu, C. Y. ,
Yang, W. H. ,
Ou, C. H. &
Jan, H. C. ,
2025 2月 ,
於: Biomedical Reports. 22 ,
2 , 32.
研究成果: Article › 同行評審
2024
Hu, C. Y. ,
Wang, Y. A. ,
Liao, K. W. ,
Wu, H. T. ,
Ou, C. H. ,
Tan, C. H. &
Lee, W. J. ,
2024 10月 ,
於: Cancers. 16 ,
19 , 3313.
研究成果: Article › 同行評審
Kuo, Y. R. ,
Lee, Y. C. ,
Wang, C. T. ,
Liu, W. C. ,
Ou, C. H. ,
Lin, K. C. ,
Cheng, T. H. ,
Jan, H. C. &
Hu, C. Y. ,
2024 5月 ,
於: Asian Journal of Surgery. 47 ,
5 ,
p. 2188-2194 7 p. 研究成果: Article › 同行評審
Renal Cell Carcinoma
100%
Fats
78%
Proportional Hazards Models
16%
Kaplan-Meier Estimate
9%
Survival Analysis
9%
Wu, K. Y. ,
Cheong, I. S. ,
Lai, J. N. ,
Hu, C. Y. ,
Hung, K. C. ,
Chen, Y. T. ,
Chiu, L. T. ,
Tsai, H. T. ,
Jou, Y. C. ,
Tzai, T. S. &
Tsai, Y. S. ,
2024 4月 ,
於: Cancer Epidemiology. 89 , 102536.
研究成果: Article › 同行評審
Survivors
100%
Carcinoma
75%
Population
44%
Neoplasms
36%
Kidney Neoplasms
29%
Yang, M-L. ,
Hu, C. Y. ,
Lee, Y. C. ,
Chang, C. C. ,
Chen, Y-C. ,
Lee, P. R. ,
Su, B. H. ,
Chen, P. C. ,
Shiau, A-L. ,
Shieh, G. S. ,
Wu, C-L. &
Wu, P. ,
2024 8月 ,
於: Stem cells translational medicine. 13 ,
8 ,
p. 738-749 12 p. 研究成果: Article › 同行評審
2023
Chou, L. P. ,
Hsu, C. W. ,
Yang, S. F. ,
Lee, C-T. ,
Ou, Y. C. ,
Lin, K. C. ,
Hu, C. Y. ,
Jou, Y. C. ,
Tsai, Y. S. &
Chow, N. H. ,
2023 8月 ,
於: Clinical Genitourinary Cancer. 21 ,
4 ,
p. 508.e1-508.e10 研究成果: Article › 同行評審
Urinary Tract
100%
Carcinoma
66%
Therapeutics
16%
Kidney Pelvis
13%
Ureter
11%
Hu, C. Y. ,
Wu, H. T. ,
Shan, Y. S. ,
Wang, C. T. ,
Shieh, G. S. ,
Wu, C. L. &
Ou, H. Y. ,
2023 4月 ,
於: International journal of molecular sciences. 24 ,
7 , 6021.
研究成果: Article › 同行評審
Lipid Peroxides
100%
Glutathione
84%
Evodiamine
78%
evodiamine
78%
Phospholipid Hydroperoxide Glutathione Peroxidase
74%
Hu, C. Y. ,
Hung, C. F. ,
Chen, P. C. ,
Hsu, J. Y. ,
Wang, C. T. ,
Lai, M. D. ,
Tsai, Y. S. ,
Shiau, A. L. ,
Shieh, G. S. &
Wu, C. L. ,
2023 10月 ,
於: Biomedicines. 11 ,
10 , 2598.
研究成果: Article › 同行評審
Oncolytic
100%
Adenoviridae
55%
Urinary Bladder Neoplasms
54%
Antitumor
52%
Dendritic Cells
51%
2022
Hu, C. Y. ,
Su, B. H. ,
Lee, Y. C. ,
Wang, C. T. ,
Yang, M. L. ,
Shen, W. T. ,
Fu, J. T. ,
Chen, S. Y. ,
Huang, W. Y. ,
Ou, C. H. ,
Tsai, Y. S. ,
Kuo, F. C. ,
Shiau, A. L. ,
Shieh, G. S. &
Wu, C. L. ,
2022 12月 ,
於: Journal of biomedical science. 29 ,
1 , 104.
研究成果: Article › 同行評審
Cachexia
100%
Long Noncoding RNA
88%
Urinary Bladder Neoplasms
78%
Cisplatin
70%
Drug Therapy
48%
Jan, H. C. ,
Hu, C. Y. ,
Wu, K. Y. ,
Tai, T. Y. ,
Weng, H. Y. ,
Yang, W-H. &
Ou, C. H. ,
2022 ,
於: Cancer Management and Research. 14 ,
p. 3139-3149 11 p. 研究成果: Article › 同行評審
Nephroureterectomy
100%
Carcinoma
48%
Inflammation
43%
Survival
26%
ROC Curve
11%
2021
Lin, Y. C. ,
Jan, H. C. ,
Ou, H. Y. ,
Ou, C. H. &
Hu, C. Y. ,
2021 8月 2 ,
於: Journal of Clinical Medicine. 10 ,
16 , 3676.
研究成果: Article › 同行評審
Mean Platelet Volume
100%
Platelet Count
70%
Renal Cell Carcinoma
70%
Survival
16%
Disease Progression
9%
Lin, K. C. ,
Jan, H. C. ,
Hu, C. Y. ,
Ou, Y. C. ,
Kao, Y. L. ,
Yang, W. H. &
Ou, C. H. ,
2021 7月 1 ,
於: Journal of Clinical Medicine. 10 ,
13 , 2983.
研究成果: Article › 同行評審
Monocytes
100%
Necrosis
93%
Lymphocytes
83%
Carcinoma
79%
Neoplasms
38%
Lee, H. C. ,
Ou, C. H. ,
Huang, Y. C. ,
Hou, P. C. ,
Creighton, C. J. ,
Lin, Y. S. ,
Hu, C. Y. &
Lin, S. C. ,
2021 4月 1 ,
於: Oncogene. 40 ,
13 ,
p. 2407-2421 15 p. 研究成果: Article › 同行評審
MDV 3100
100%
Lipid Metabolism
65%
Prostatic Neoplasms
53%
Proteins
24%
Neoplasms
21%
2020
Jan, H. C. ,
Hu, C. Y. ,
Yang, W. H. &
Ou, C. H. ,
2020 8月 ,
於: Clinical Genitourinary Cancer. 18 ,
4 ,
p. e484-e500 研究成果: Article › 同行評審
Monocytes
100%
Blood Platelets
94%
Lymphocytes
83%
Carcinoma
79%
Neoplasms
38%
Huang, R. L. ,
Li, C. H. ,
Du, Y. F. ,
Cheng, K. P. ,
Lin, C. H. ,
Hu, C. Y. ,
Wu, J. S. ,
Chang, C. J. ,
Wu, H. T. &
Ou, H. Y. ,
2020 1月 1 ,
於: BioFactors. 46 ,
1 ,
p. 100-105 6 p. 研究成果: Article › 同行評審
Obesity
100%
Insulin Derivative
97%
Overweight
95%
Weight
76%
High-Density Lipoprotein Cholesterol
75%
2019
Lin, C. C. ,
Cheng, K. P. ,
Hung, H. C. ,
Li, C. H. ,
Lin, C. H. ,
Chang, C. J. ,
Hu, C. Y. ,
Wu, H. T. &
Ou, H. Y. ,
2019 9月 ,
於: Journal of Clinical Medicine. 8 ,
9 , 1436.
研究成果: Article › 同行評審
secretogranin III
100%
Fasting
40%
Glucose
31%
Serum
22%
Endocrine Cells
10%
2018
Hu, C. Y. ,
Huang, C. Y. ,
Huang, K. H. ,
Tai, H. C. ,
Lin, Y. M. &
Tai, T. Y. ,
2018 1月 1 ,
於: Urological Science. 29 ,
1 ,
p. 33-37 5 p. 研究成果: Article › 同行評審
Nephroureterectomy
100%
Kidney Pelvis
60%
Hand
55%
Ureter
52%
Carcinoma
24%
Ou, Y. C. ,
Hu, C. Y. ,
Cheng, H. L. &
Yang, W. H. ,
2018 8月 31 ,
於: BMC Urology. 18 ,
1 , 73.
研究成果: Article › 同行評審
Ureteral Neoplasms
100%
Kidney
16%
Therapeutics
9%
Carcinoma
8%
Ureter
6%
2017
Hu, C. Y. ,
Wu, H. T. ,
Su, Y. C. ,
Lin, C. H. ,
Chang, C. J. &
Wu, C. L. ,
2017 7月 14 ,
於: Molecules (Basel, Switzerland). 22 ,
7 研究成果: Article › 同行評審
Evodiamine
100%
evodiamine
99%
cancer
54%
Hepatocellular Carcinoma
47%
mice
22%
Ou, H. Y. ,
Wu, H. T. ,
Lin, C. H. ,
Du, Y. F. ,
Hu, C. Y. ,
Hung, H. C. ,
Wu, P. ,
Li, H. Y. ,
Wang, S. H. &
Chang, C. J. ,
2017 7月 1 ,
於: Journal of Clinical Endocrinology and Metabolism. 102 ,
7 ,
p. 2407-2415 9 p. 研究成果: Article › 同行評審
Hyperglycemic
100%
Liver
33%
Hyperglycemia
17%
Superoxide Dismutase-1
16%
Obese Mice
15%
2015
Hu, C. Y. ,
Yang, C. K. ,
Huang, C. Y. ,
Ou, Y. C. ,
Hung, S. F. ,
Chung, S. D. &
Pu, Y. S. ,
2015 ,
於: BioMed research international. 2015 , 918486.
研究成果: Article › 同行評審
Nephroureterectomy
100%
Urinary Tract
73%
Hand
55%
Carcinoma
48%
Robotics
38%
Hu, C. Y. ,
Tsai, Y. C. ,
Wang, S. M. ,
Huang, C. Y. ,
Tai, H. C. ,
Chen, C. H. ,
Pu, Y. S. ,
Lin, W. C. &
Huang, K. H. ,
2015 ,
於: BioMed research international. 2015 , 527976.
研究成果: Article › 同行評審
Nephroureterectomy
100%
Urinary Tract
73%
Urinary Bladder
58%
Carcinoma
48%
Diabetes Mellitus
39%